Tom Vasicek

Title: The Innovations of Tom Vasicek

Introduction

Tom Vasicek is an accomplished inventor based in Minneapolis, MN. He has made significant contributions to the field of molecular diagnostics, particularly in the study of melanocytic lesions and improvements in quantitative nuclease protection assays.

Latest Patents

Tom Vasicek holds 2 patents. His latest patents include methods for determining whether a melanocyte-containing sample, such as a nevus or other pigmented lesion, is benign or a primary melanoma. These methods involve detecting the expression of at least two disclosed genes at the molecular level in a biological sample obtained from a subject. Additionally, he has developed improvements to quantitative Nuclease Protection Assay (qNPA) and quantitative Nuclease Protection Sequencing (qNPS) methods. These improvements utilize nuclease protection probes that include flanking sequences, enhancing the ability to sequence or detect target nucleic acid molecules.

Career Highlights

Throughout his career, Tom has worked with notable companies such as Htg Molecular Diagnostics, Inc. and the John Wayne Cancer Institute. His work has focused on advancing molecular diagnostic techniques that can significantly impact patient care.

Collaborations

Tom has collaborated with professionals like Bruce Seligmann and Debrah Thompson, contributing to the advancement of research in his field.

Conclusion

Tom Vasicek's innovative work in molecular diagnostics showcases his dedication to improving medical technologies. His patents and career achievements reflect his significant impact on the field.